Beacon Associates LLC

Beacon Associates LLC

制药业

Chester,New Jersey 32 位关注者

Advancing availability, access & adoption of innovative patient & consumer centric healthcare solutions. Rx-to-OTC, ACNU

关于我们

Consumer / patient centric healthcare strategic marketing and consultancy | Driving availability, access and adoption of innovative healthcare solutions | Rx-to-OTC switch | ACNU | Patient Access | DTC Contact: [email protected] We strive to synthesize complexity to identify the "beacons" of insight that drive strategic imperatives and inspire brand building growth. Extensive expertise in consumer/patient healthcare access (Rx to OTC Switch, ACNU, Technology assisted access) across many therapeutic areas. Developing strategic plans, development strategies and executional solutions to address consumer and product development barriers. Ready to work with your team to activate initiatives that advance patient health and drive differentiated, sustainable business growth. - Rx to OTC Switch (Understanding the switch process, best practices & key success factors; labeling & packaging development; benefit / risk assessment; issues management, program & behavioral studies; commercial business planning & launch) - Technology assisted access to Rx & OTC products including ACNUs (Additional conditions for non-prescription use) - Strategic analytics & business assessments - Defining & mining the patient journey to develop insight - Developing global & local brand building growth strategies - Behavioral marketing including digital & ecommerce - Lifecycle management & innovation: new product development, claims & technology CHPA member. What does patient/consumer centric mean for Beacon Associates? WHO definition: self-care is “the ability of individuals, families and communities to promote health, prevent disease, maintain health, and to cope with illness and disability with or without the support of a healthcare provider”. - Patient understanding & engagement drives improved awareness, acquisition and adherence resulting sustainable business growth - An engaged and motivated consumer leads to improved self-management and self-care

所属行业
制药业
规模
1 人
总部
Chester,New Jersey
类型
私人持股
创立
2020
领域
Healthcare Strategic Marketing、Rx to OTC Switch、Global & Local Brand Building、Patient Journey、Consumer & Patient Marketing、Behavior Change、Strategic Analytics、Insight Generation、Private Equity、Business Assessments、Consulting、Business Development、Outsourced Marketing、ecommerce、Digital Marketing、New Product Innovation、Launch、ACNU、Patient Access、DTC和Patient engagement

地点

Beacon Associates LLC员工

动态

  • Beacon Associates LLC转发了

    查看Paul Wardle的档案,图片

    Healthcare Strategy & Marketing | Global Brand Building | Business Model Innovation | Rx, ACNU, Rx-to-OTC switch, OTC | Self-directed Healthcare | Patient Access | Consulting

    Wishing all a Happy New Year and a year for bold new strategies to reduce barriers for accessing healthcare, helping address health equity and increasing patient/consumer engagement in their own health. With just a few months until the FDA target finalization date for the proposed ACNU rule, I am re-sharing a podcast recorded with Rusty Ray at Alantra and a link to a recent publication co-authored with Alfred Whitehead and Erin Oliver, both of which discuss the potential for this proposed rule. https://lnkd.in/d79ZH2Vy Tune in or take a read, but above all else, let's take steps to help address barriers to healthcare access in 2024. #selfcare #BeaconAssociates #RAPS #CHPA #patientcare #healthequity

    查看Regulatory Affairs Professionals Society (RAPS)的公司主页,图片

    177,990 位关注者

    Significant portions of the population remain undertreated or untreated for their medical conditions despite the availability of branded and generic pharmaceutical medicines and higher numbers of people with medical insurance. Paul Wardle, Alfred Whitehead, MA, MS, and Erin Oliver discuss a novel regulatory pathway proposed by the US Food and Drug Administration intended to improve public health by expanding the types of drug products available directly to patients without a prescription in this article from the latest issue of RF Quarterly. RAPS members get exclusive access to this article: https://bit.ly/3RnP0w4

    • 该图片无替代文字
  • 查看Beacon Associates LLC的公司主页,图片

    32 位关注者

    There are many commercial & regulatory reasons to consider the potential of ACNU to increase medication access in a new patient group, extend the branded lifecycle while retaining current business. #selfcare #ACNU #BeaconAssociates

    查看Alantra的公司主页,图片

    104,324 位关注者

    On the latest episode of Crossroads by Alantra, Rusty Ray, Head of US Healthcare at Alantra, is joined by Paul Wardle, Founder & Principal of Beacon Associates, LLC., who led switches at HRA Pharma and Pfizer and worked on iconic switch brands such as Viagra, Advil, Lipitor, and Opill. They delve into the details of their latest #CrossroadsbyAlantra discussion, focusing on ACNU - the FDA's proposed rule on non-prescription drug products with additional conditions for non-prescriptive use. ?? Tune in to listen to the full episode here: https://lnkd.in/d79ZH2Vy ?? For more on #ConsumerHealth, check out our Crossroads by Alantra podcast: https://lnkd.in/dUpD-XuW #InvestmentBanking #ConsumerHealth #Healthcare #Trends #CrossroadsbyAlantra

  • 查看Beacon Associates LLC的公司主页,图片

    32 位关注者

    Facilitating consumer self-directed healthcare! The potential of novel patient engagement strategies. The financial and non-financal barriers to appropriate medication access are complex resulting in unmet needs across most therapeutic categories. So it should not surprise us that, as individuals, the majority of us are looking for new ways to effectively manage our own health needs. The cited article, which was recently published, discusses a novel FDA proposed regulatory pathway to facilitate self-directed care. The proposed ACNU NDA has the potential to enhance patient engagement; fill some of the gaps in health equity; and improve public health across a broad range of acute and chronic conditions. Addressing the behavioral psychology of patient perspectives and preferences with innovative, yet practical, technology solutions has the promise to increase appropriate medication reach and extend the lifecycle with consumer facing pharmaceutical brands. Thank you to my co-authors Alfred Whitehead and Erin Oliver as well as the editorial team at RAPS led by Renee Matthews for your inspiring collaboration on this article which followed our presentation at RAPS Convergence 2023. Do reach out to discuss the full article. #selfcare #BeaconAssociates Citation?Wardle P, et al. Facilitating self-directed care: The FDA’s proposed ACNU rule. RF Quarterly. 2023;3(4);12-22. Published online 8 December 2023.?https://lnkd.in/eufn5Nj7

    • 该图片无替代文字

相似主页

查看职位